• Press Releases
    • 08/06/19
      Alzheimer’s Memory Loss Reversed by Easy-to-Wear Head Device from NeuroEM Therapeutics
    • 08/06/19
      A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging
    • 01/08/19
      NeuroEM Therapeutics Announces Completion of Clinical Trial Testing Its Novel Head Device Against Alzheimer’s Disease
    • 07/28/17
      Alzheimer’s Clinical Trial Begins with Pioneering Medical Device
    • 12/08/16
      National Institutes of Health Bestows Grant to NeuroEM Therapeutics and Arizona State University for Collaborative Research in Alzheimer’s Disease
    • 11/23/16
      NeuroEM Therapeutic’s CEO provides keynote address at Australian conference on biologic effects of electromagnetic exposure
    • 05/02/16
      Angel Investment Forum Provides “Series Seed” Funding to NeuroEM Therapeutics to Support Development of Medical Device against Alzheimer’s Disease
    • 02/19/16
      NeuroEM Therapeutics Secures over Half Million Dollars in Funding to Perform Clinical Trial Testing It’s Medical Device for Alzheimer’s Disease
    • 01/04/16
      NeuroEM Therapeutics Receives Clinical Trial Approval to Test its Novel Head Device in Alzheimer’s Patients